Glyceryl Trierucate ( DrugBank: Glyceryl Trierucate )

---

1 disease

ID	Disease name (Link within this page)	Number of trials
20	Adrenoleukodystrophy	2

20. Adrenoleukodystrophy

---

Clinical trials : 53 /  Drugs : 88 - (DrugBank : 31) / Drug target genes : 23 - Drug target pathways : 123

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00004450 (ClinicalTrials.gov)	August 1998	18/10/1999	Randomized Study of Beta Interferon and Thalidomide in Patients With Adrenoleukodystrophy		Adrenoleukodystrophy	Drug: glyceryl trierucate;Drug: glyceryl trioleate;Drug: interferon beta;Drug: thalidomide	FDA Office of Orphan Products Development	Hugo W. Moser Research Institute at Kennedy Krieger, Inc.	Completed	4 Years	N/A	Male	60	N/A	NULL
2	NCT00004418 (ClinicalTrials.gov)	April 1998	18/10/1999	Effect of Glycerol Trierucate on Clinical Course of Adrenoleukodystrophy	Study of Glyceryl Trierucate and Glyceryl Trioleate (Lorenzo's Oil) Therapy in Male Children With Adrenoleukodystrophy	Adrenoleukodystrophy	Drug: glyceryl trierucate/glyceryl trioleate	Hugo W. Moser Research Institute at Kennedy Krieger, Inc.	NULL	Terminated	18 Months	8 Years	Male	126	Phase 2	United States